Progress in the control of hepatitis B infection in the Western Pacific Region
- PMID: 16361001
- DOI: 10.1016/j.vaccine.2005.11.035
Progress in the control of hepatitis B infection in the Western Pacific Region
Abstract
Hepatitis B virus infection is a serious problem globally, and particularly in the Western Pacific Region where the population suffers disproportionately from the infection and its sequelae. By 2001, every immunization programme in the Region had included hepatitis B vaccine in their schedule. However, many challenges remain if every one of the 26 million children born in the 37 countries and areas of the Region each year is to be protected against hepatitis B infection. In 2003, the Regional Committee of the World Health Organization's Western Pacific Region resolved to improve hepatitis B control by making it one of two new pillars for strengthening the Expanded Programme on Immunization. The Committee endorsed the strategies of the Regional Plan to improve hepatitis B control through immunization, reducing chronic HBV infection (chronic carriage rate) to less than 1%, and aiming for coverage of at least 80% of the birth cohort in every district with three doses of hepatitis B vaccine by 2005. To help guide this process, an assessment was made of the progress to date, and is reported in this paper. Coverage data used in this evaluation were not independently verified, and could over-estimate progress made in some countries. Whilst there has indeed been great progress in the Region, a number of national programmes still lack the ability to reach all children with immunization services. Other major issues that need to be addressed are the challenges of delivering a timely birth dose, and for certain countries, the affordability of the vaccine over the short- and long-term.
Similar articles
-
Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.J Viral Hepat. 2008 Jan;15(1):14-9. doi: 10.1111/j.1365-2893.2007.00890.x. J Viral Hepat. 2008. PMID: 18088240
-
Priorities and challenges for hepatitis B control in the Philippines and the importance of a vaccine dose at birth.Southeast Asian J Trop Med Public Health. 2009 Sep;40(5):972-90. Southeast Asian J Trop Med Public Health. 2009. PMID: 19842381 Review.
-
Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.Vaccine. 2004 Jul 29;22(21-22):2791-9. doi: 10.1016/j.vaccine.2004.01.046. Vaccine. 2004. PMID: 15246613
-
Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.Int J Infect Dis. 2008 Mar;12(2):183-9. doi: 10.1016/j.ijid.2007.06.010. Epub 2007 Oct 2. Int J Infect Dis. 2008. PMID: 17913535
-
The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.Vaccine. 2013 Dec 27;31 Suppl 9:J15-20. doi: 10.1016/j.vaccine.2013.03.045. Vaccine. 2013. PMID: 24331015 Review.
Cited by
-
Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China.Hepatology. 2010 Feb;51(2):405-14. doi: 10.1002/hep.23310. Hepatology. 2010. PMID: 19839061 Free PMC article.
-
Hepatitis B Virus Infection in Indonesia 15 Years After Adoption of a Universal Infant Vaccination Program: Possible Impacts of Low Birth Dose Coverage and a Vaccine-Escape Mutant.Am J Trop Med Hyg. 2016 Sep 7;95(3):674-9. doi: 10.4269/ajtmh.15-0121. Epub 2016 Jul 11. Am J Trop Med Hyg. 2016. PMID: 27402524 Free PMC article.
-
Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area.Sci Rep. 2017 Apr 27;7(1):1212. doi: 10.1038/s41598-017-01234-0. Sci Rep. 2017. PMID: 28450703 Free PMC article.
-
Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.Vaccine. 2013 Sep 13;31(40):4459-64. doi: 10.1016/j.vaccine.2013.05.009. Epub 2013 May 15. Vaccine. 2013. PMID: 23684825 Free PMC article.
-
Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases.World J Gastroenterol. 2021 Nov 21;27(43):7497-7508. doi: 10.3748/wjg.v27.i43.7497. World J Gastroenterol. 2021. PMID: 34887645 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical